<VariationArchive VariationID="3457" VariationName="NM_015087.5(SPART):c.1110del (p.Lys370fs)" VariationType="Deletion" Accession="VCV000003457" Version="9" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-10" DateCreated="2017-06-29" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18496" VariationID="3457">
      <GeneList>
        <Gene Symbol="SPART" FullName="spartin" GeneID="23111" HGNC_ID="HGNC:18514" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="36301638" stop="36370180" display_start="36301638" display_stop="36370180" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="36875774" stop="36944316" display_start="36875774" display_stop="36944316" Strand="-" />
          </Location>
          <OMIM>607111</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015087.5(SPART):c.1110del (p.Lys370fs)</Name>
      <CanonicalSPDI>NC_000013.11:36329415:TTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="36329416" stop="36329416" display_start="36329416" display_stop="36329416" variantLength="1" positionVCF="36329415" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="36903553" stop="36903553" display_start="36903553" display_stop="36903553" variantLength="1" positionVCF="36903552" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>SPART, 1-BP DEL, 1110A</Name>
      </OtherNameList>
      <ProteinChange>K370fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015087.4" sequenceAccession="NM_015087" sequenceVersion="4" change="c.1110del">
            <Expression>NM_015087.4:c.1110del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.36903555del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.36903555del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.36329418del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.36329418del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011559.2" sequenceAccession="NG_011559" sequenceVersion="2" change="g.45765del">
            <Expression>NG_011559.2:g.45765del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142294.2" sequenceAccession="NM_001142294" sequenceVersion="2" change="c.1110del">
            <Expression>NM_001142294.2:c.1110del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001135766.1" sequenceAccession="NP_001135766" sequenceVersion="1" change="p.Lys370fs">
            <Expression>NP_001135766.1:p.Lys370fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142295.2" sequenceAccession="NM_001142295" sequenceVersion="2" change="c.1110del">
            <Expression>NM_001142295.2:c.1110del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001135767.1" sequenceAccession="NP_001135767" sequenceVersion="1" change="p.Lys370fs">
            <Expression>NP_001135767.1:p.Lys370fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142296.2" sequenceAccession="NM_001142296" sequenceVersion="2" change="c.1110del">
            <Expression>NM_001142296.2:c.1110del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001135768.1" sequenceAccession="NP_001135768" sequenceVersion="1" change="p.Lys370fs">
            <Expression>NP_001135768.1:p.Lys370fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015087.5" sequenceAccession="NM_015087" sequenceVersion="5" change="c.1110del" MANESelect="true">
            <Expression>NM_015087.5:c.1110del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055902.1" sequenceAccession="NP_055902" sequenceVersion="1" change="p.Lys370fs">
            <Expression>NP_055902.1:p.Lys370fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16609332" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607111.0001" DB="OMIM" />
        <XRef Type="rs" ID="1060499524" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015087.5(SPART):c.1110del (p.Lys370fs) AND Troyer syndrome" Accession="RCV000003621" Version="5">
        <ClassifiedConditionList TraitSetID="887">
          <ClassifiedCondition DB="MedGen" ID="C0393559">Troyer syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-22" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015087.5(SPART):c.1110del (p.Lys370fs) AND not provided" Accession="RCV001008821" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-07-08" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015087.5(SPART):c.1110del (p.Lys370fs) AND SPART-related disorder" Accession="RCV003904801" Version="1">
        <ClassifiedConditionList TraitSetID="90196">
          <ClassifiedCondition>SPART-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-17" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-06-29" MostRecentSubmission="2024-03-16">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12134148</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18413476</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20437587</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20504295</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="887" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5934" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Troyer syndrome</ElementValue>
                <XRef ID="MONDO:0010156" DB="MONDO" />
                <XRef ID="230264003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia autosomal recessive Troyer type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal recessive spastic paraplegia type 20</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraparesis childhood-onset with distal muscle wasting</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 20</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SPG20</ElementValue>
                <XRef Type="MIM" ID="275900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Troyer syndrome is characterized by progressive spastic paraparesis, dysarthria, pseudobulbar palsy, distal amyotrophy, short stature, and subtle skeletal abnormalities. Most affected children exhibit delays in walking and speech and difficulty in managing oral secretions, followed by increased lower-limb spasticity and slow deterioration in both gait and speech. Mild cerebellar signs are common. The most severely affected individuals have choreoathetosis. Emotional lability / difficulty in controlling emotions and affective disorders, such as inappropriate euphoria and/or crying, are frequently described. Life expectancy is normal.</Attribute>
                <XRef ID="NBK1382" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5372" />
                <XRef ID="5372" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301556</ID>
                <ID Source="BookShelf">NBK1382</ID>
              </Citation>
              <XRef ID="101000" DB="Orphanet" />
              <XRef ID="C0393559" DB="MedGen" />
              <XRef ID="MONDO:0010156" DB="MONDO" />
              <XRef Type="MIM" ID="275900" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="90196" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="71958" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPART-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">SPART-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23784" SubmissionDate="2017-06-26" DateLastUpdated="2017-06-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607111.0001_SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE" title="SPART, 1-BP DEL, 1110A_SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE" />
        <ClinVarAccession Accession="SCV000023784" DateUpdated="2017-06-29" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In Amish patients with Troyer syndrome (275900), Patel et al. (2002) identified a homozygous 1-bp deletion (1110delA) in exon 4 of the SPG20, predicted to result in a truncated protein. Sequencing of RNA from lymphocytes from affected individuals, carrier parents, and normal controls showed the mutation in the RNA transcripts in individuals with Troyer syndrome. The mutation was not found in 760 normal control chromosomes of mixed Caucasian, Asian, and African descent or in 100 chromosomes from individuals from the same and neighboring Amish communities who were not close relatives of the individuals with Troyer syndrome.</Attribute>
              <Citation>
                <ID Source="PubMed">12134148</ID>
              </Citation>
              <XRef DB="OMIM" ID="275900" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Bakowska et al. (2008) identified the 1110delA mutation in 2 Amish sibs with Troyer syndrome. Studies on patient fibroblasts and lymphoblasts showed spartin mRNA transcripts, but no translated protein, consistent with complete loss of function.</Attribute>
              <Citation>
                <ID Source="PubMed">18413476</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPART" />
          </GeneList>
          <Name>SPART, 1-BP DEL, 1110A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1110A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607111.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2306616" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:767579|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001168623" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1110delA variant in the SPG20 gene has been reported previously in the homozygous state in association with Troyer syndrome (Patel et al., 2002; Bakowska et al., 2008). The c.1110delA variant is considered a founder mutation in the Old Order Amish population (Patel et al., 2002). The c.1110delA pathogenic variant causes a frameshift starting with codon Lysine 370, changes this amino acid to an Asparagine residue and creates a premature Stop codon at position 30 of the new reading frame, denoted p.Lys370AsnfsX30. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Furthermore, the c.1110delA variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). We interpret c.1110delA as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG20" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015087.4:c.1110delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7914526" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="e6c2d001f23e9d284252ac7d1fefd70867365b37170802f81f992376dbceed41|OMIM:275900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004238366" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015087.5:c.1110del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="275900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2378096" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="2754182|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001212740" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18413476</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20437587</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20504295</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12134148</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18413476</ID>
          </Citation>
          <Comment>This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Lys370Asnfs*30) in the SPART gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPART are known to be pathogenic (PMID: 18413476, 20437587, 20504295). This premature translational stop signal has been observed in individuals with Troyer syndrome (PMID: 12134148, 18413476). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 3457). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPART" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.36903553del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8803435" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="16144399|SPART-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004727602" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The SPART c.1110delA variant is predicted to result in a frameshift and premature protein termination (p.Lys370Asnfs*30). This variant was reported in the homozygous state in many Old Order Amish with Troyer syndrome (Patel et al 2002. PubMed ID: 12134148; Bakowska JC et al 2008. PubMed ID: 18413476). This variant is reported in 0.0015% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in SPART are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPART" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015087.4:c.1110delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPART-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2306616" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8803435" TraitType="Disease" MappingType="Name" MappingValue="SPART-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="SPART-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2378096" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7914526" TraitType="Disease" MappingType="XRef" MappingValue="275900" MappingRef="OMIM">
        <MedGen CUI="C0393559" Name="Troyer syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="23784" TraitType="Disease" MappingType="Name" MappingValue="SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE" MappingRef="Preferred">
        <MedGen CUI="C0393559" Name="Troyer syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

